Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Supporting Data-Driven Decision-Making for Substance Use Services and Overdose Prevention

Award Number: R33DA059163
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/01/2023
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Supporting Data-Driven Decision-Making for Substance Use Services and Overdose Prevention - PROJECT SUMMARY Cross-sector decision makers—such as behavioral health and public health service providers, justice, and insurers—are calling for actionable data to be collected and shared in sustainable, useful ways. Oregon ranks last in the U.S. for access to substance use (SU) services and first in opioid and methamphetamine use. A recent state-wide analysis estimated that service gaps may even be larger than previously estimated. The proposed study aims to make data that are relevant to decision makers available to them in easy-to-use formats so that they can make timely, evidence-informed decisions to reduce SU service gaps and overdoses and ultimately improve health. Oregon provides an opportunity to observe decision-making in a first-of-its-kind funding initiative—Ballot Measure 110 (M110). M110 is bringing unprecedented levels of funding to expand services aligned with the pillars of overdose prevention statewide, and it decriminalized the possession of personal amounts of substances. Both critics and proponents of M110 have called for better data to provide a holistic picture of SU service and service-recipient impacts, and to inform looming decisions such as how to allocate opioid settlement funds. To meet this need, consistent with goals of the NIH Helping to End Addiction Long-term Data2Action Program call for Innovation Projects with cross-sector partnerships, we propose to develop, refine, and test an implementation strategy—Co-Design Sessions (CDS)—to engage cross-sector decision makers in conversations about what data are of priority to them and to develop feasible protocols for disseminating data through products that they co-design (e.g., reports, simulations, dashboards). In the R61 phase, we will strengthen and expand existing partnerships with five types of decision makers, including state agencies responsible for monitoring and/or implementing SU service and funding changes and for maintaining a statewide data repository. CDS, CDS-generated data products, and co-developed protocols for data sharing and for study-generated data collection will be refined for feasibility and testing. In the R33 phase, counties will be cluster randomized to participate in CDS and receive fully tailored data products (N = 18) or to later receive products only (N = 18) in a stepped-wedge design. We will: (Aim 1) identify whether CDS is an efficient, generalizable strategy to optimize implementation of SU service decision quality based on the comparative usability of CDS-generated data products between counties; (Aim 2) test the impact of CDS on SU service gaps and service-recipient outcomes, as well as cross-sector collaboration; and (Aim 3) examine whether CDS-generated data products are associated with concrete actions (e.g., funding) to strengthen the availability and quality of evidence-based, locally-responsive SU services. Based on study results and partners’ input, we will provide behavioral health decision makers with protocols for supporting sustainment of study infrastructure and output, including: feasible methods for prioritized data collection and data product dissemination, and local priorities for a state-wide SU data infrastructure. The proposed study holds strong potential for immediate, real-world impact.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,016,982 )
2026	2026	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Use and Addiction Research Programs	000	4	8/25/2026	NON-COMPETING CONTINUATION	$1,016,982
														Subtotal = $1,016,982

Issue Date FY: 2025 ( Subtotal = $1,018,107 )
2025	2025	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Use and Addiction Research Programs	001	3	9/4/2025	NON-COMPETING CONTINUATION	$1,018,107
2025	2024	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Use and Addiction Research Programs	000	2	2/27/2025	EXTENSION WITH OR WITHOUT FUNDS	$0
														Subtotal = $1,018,107

Issue Date FY: 2024 ( Subtotal = $1,015,880 )
2024	2024	CHESTNUT HEALTH SYSTEMS INC	1003 MARTIN LUTHER KING DR	BLOOMINGTON	IL	61701	MCLEAN	USA	Drug Use and Addiction Research Programs	000	2	9/13/2024	EXTENSION WITH OR WITHOUT FUNDS	$1,015,880
														Subtotal = $1,015,880

Grand Total All Awards = $3,050,969

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Supporting Data-Driven Decision-Making for Substance Use Services and Overdose Prevention

Award Number: R33DA059163

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/01/2023

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer